Which mutual funds hold Zota Health Care LImited?
1 fund houses holding · net −15,608 shares (−0.05 pp of equity) · Oct 2026 vs Sep 2026
1 fund houses holding · net −15,608 shares (−0.05 pp of equity) · Oct 2026 vs Sep 2026
| % of equity, Oct 2026 | Activity | Source | |||||
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Mutual Fund | 2 | 1.27 lakh0.37% | 1.11 lakh0.32% | ▼ −15,608▼ −0.05 pp | 0.32% | Reduced | Disclosure ↗ |
| WhiteOak Capital Mutual Fund | 2 | 1.27 lakh0.37% | 1.11 lakh0.32% | ▼ −15,608▼ −0.05 pp | 0.32% | Reduced | Disclosure ↗ |
No fund house is in this bucket for Oct 2026.
Source: each AMC's SEBI monthly portfolio disclosure, Oct 2026. Report a wrong number
Shares as disclosed; % of equity uses 3.46 cr shares outstanding (NSE, 20 Nov 2026) for both months. "Not compared" = the fund house has no Sep 2026 portfolio.
| Scheme | Fund house | Shares | % of scheme | Rank in scheme | % of scheme vs Jul 2026 | Shares vs Jul 2026 | Months in a row |
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Special Opportunities Fund | WhiteOak Capital Mutual Fund | 82,113 | 0.54% | 53 of 80 (was 48) | −0.15 pp | −15,608 | — |
| WhiteOak Capital Pharma and Healthcare Fund | WhiteOak Capital Mutual Fund | 28,827 | 0.40% | 47 of 52 (was 45) | −0.05 pp | 0 | — |
Source: each AMC's SEBI monthly portfolio disclosure, Oct 2026 and Jul 2026. Report a wrong number
Index and arbitrage schemes included. Rank: by value among the scheme's equity holdings (1 = largest). Jul 2026: the same scheme's portfolio three months before; shares in Oct 2026's units (split or bonus adjusted). Months in a row: months the scheme's share count went up (bought) or down (sold), each month against the one before.